Insmed (INSM) Payables (2010 - 2026)
Insmed (INSM) reported Payables of $428.93 million for Q2 2026, up 40.6% from $305.02 million a year earlier and up 21.7% from the prior quarter.
Analysis
Insmed (INSM) Payables (2010 - 2026) Analysis & Trends
At the end of FY2025, Insmed posted Payables of $456.06 million, up 59.9% from FY2024.
- Payables has increased for six consecutive years, with a five-year compound annual growth rate of 60.5% (FY2020 to FY2025).
- By year, Payables came in at $285.21 million in FY2024 (+32.7%), $214.99 million in FY2023 (+18.0%), $182.12 million in FY2022 (+45.7%) and $125.03 million in FY2021 (+191.8%).
- Five-year quarterly Payables spans a low of $23.53 million in Q3 2021 and a high of $456.06 million in Q4 2025.
- Year over year, Payables has now increased in each of the last 25 quarters, with growth averaging 38.7% over the last eight quarters.
- Over the past five years, the year-over-year growth in Payables ranged from 0.2% (Q2 2022) to 534.6% (Q2 2023).
- Per Business Quant data, the three quarters before Q2 2026 came in at $352.56 million (Q1 2026), $456.06 million (Q4 2025) and $409.84 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Insmed | 25.69 Bn | 20.19 Bn | 358.27 Mn | 428.93 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 428.93 Mn |
| Mar 31, 2026 | 352.56 Mn |
| Dec 31, 2025 | 456.06 Mn |
| Sep 30, 2025 | 409.84 Mn |
| Jun 30, 2025 | 305.02 Mn |
| Mar 31, 2025 | 232.67 Mn |
| Dec 31, 2024 | 285.21 Mn |
| Sep 30, 2024 | 248.68 Mn |
| Jun 30, 2024 | 290.84 Mn |
| Mar 31, 2024 | 189.36 Mn |
| Dec 31, 2023 | 214.99 Mn |
| Sep 30, 2023 | 187.78 Mn |
| Jun 30, 2023 | 197.65 Mn |
| Mar 31, 2023 | 179.01 Mn |
| Dec 31, 2022 | 182.12 Mn |
| Sep 30, 2022 | 131.86 Mn |
| Jun 30, 2022 | 31.14 Mn |
| Mar 31, 2022 | 48.57 Mn |
| Dec 31, 2021 | 125.03 Mn |
| Sep 30, 2021 | 23.53 Mn |
API Access
Insmed Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=INSM&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "INSM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=INSM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();